Santen Pharmaceutical
4536.T
$9.40
Share price
0.66%
Change (1 day)
16.63%
Change (1 year)
Categories
Santen Pharmaceutical (4536.T) - P/B ratio
P/B ratio as of April 2024 : 1.60
According to Santen Pharmaceutical
's latest financial reports the company has a price-to-book ratio of 1.60.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Santen Pharmaceutical - P/B ratio (from 2009 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 1.72 | 26.35% |
| 2022-12-31 | 1.36 | -22.54% |
| 2021-12-31 | 1.75 | -17.53% |
| 2020-12-31 | 2.13 | -22.41% |
| 2019-12-31 | 2.74 | 26.83% |
| 2018-12-31 | 2.16 | -15.39% |
| 2017-12-31 | 2.55 | 9.01% |
| 2016-12-31 | 2.34 | -26.98% |
| 2015-12-31 | 3.21 | 17.38% |
| 2014-12-31 | 2.73 | 20.47% |
| 2013-12-31 | 2.27 | 31.27% |
| 2012-12-31 | 1.73 | 2.43% |
| 2011-12-31 | 1.69 | 1.13% |
| 2010-12-31 | 1.67 | -9.5% |
| 2009-12-31 | 1.84 |